info@symbiosisip.co.uk

Changes to UK Intellectual Property Office (UKIPO) Patent Practise

Author: Dr Julie Myint | julie@symbiosisip.co.uk

1 Dec 2020

#

The address for service for the purpose of corresponding with the UKIPO and also for the purposes of proceedings under IP legislation must be an address within the UK[1] from 1 January 2021.

It can be a home or business address or the address of your attorney or representative.

Prior to the 31 December 2020, Applicants filing a patent application were able to use an address in the UK or the European Economic Area (EEA). However, on 1 January 2021 the UKIPO’s rules on address for service will change and Applicants will need an address in the UK, Isle of Man, Gibraltar or the Channel Islands (for brevity ‘the UK’) before the UKIPO will consider an action. This means an address in the EEA will no longer be accepted.

Notably, the UKIPO is not changing the way it processes any forms or changing any procedures.

Defending and Challenging rights

Granted patents may be challenged by revocation and/or invalidity proceedings. If your patent right is challenged, on or after 1 January 2021, and your address for service is outside the UK, you will need to provide an address in the UK to engage in those proceedings. If you do not do this then the proceedings against you could succeed (without your involvement) and you could lose your patent right.

If you wish to challenge a granted UK patent, you must provide an address for service in the UK.

European Patents

Granted European Patents which designate the UK are transferred onto the UK Register automatically. They are transferred with the Applicant’s details only, as the UKIPO must receive authorisation/power of attorney (Form 51) before it can recognise any representative. This is current practice and will not change. This is the case even if your European Patent had the address of a UK representative who acted for you at the European Patent Office.

From 1 January 2021 if you wish to appoint a representative for the UK granted part of your European patent application, the representative will need to have an address in the UK.

Exceptions

However, you will not need a UK address to renew a granted UK patent or a EP(UK) granted patent. This is in line with the current renewal arrangements which do not require a valid address for service.

Further, for actions started before 1 January 2021 and still ongoing, if you have used an EEA address for service you will not need to change your address for a UK address to conclude them. This includes proceedings such as:

•             oppositions

•             invalidations, or

•             revocations

•             a hearing

•             an extension of time, or

•             a request to divide an application

If you need to change your EEA address during any such ongoing proceedings, you may change it to another EEA or UK address.

If you need to change your UK address during any such ongoing proceedings, you will need to provide a replacement address in the UK, i.e. an EEA address cannot be appointed.

If you filed a new application before the 1 January 2021 you can retain your EEA address. However, as mentioned above, if a proceeding is initiated against your patent right on or after 1 January 2021, a UK address for service will subsequently be required.

If you make a request after 1 January 2021 to divide an application which you filed before 1 January 2021, the new divisional application will be able to retain the same address for service as the original application.

"Driven, dedicated and knowledgeable in the whole spectrum of work covering commercialisation of technology"

UK University Senior Tech Transfer

"Result oriented, very responsive, a value creator and a person with a clear vision and strategy"

Senior Corporate Counsel

"Vast experience in commercialising science and technology"

Senior UK Patent Attorney

"Our two companies collaborate very well together to optimise the commercial benefits of the Glycologic Limited portfolio of activities."

Richard Tester
Managing Director, Glycologic Limited

"Symbiosis maximises the value of IP generated by our inventors in a cost effective and efficient manner that meets our commercial objectives."

Martin Whitaker
CEO, Diurnal

"Mark Hoggins consistently delivers excellent service and detailed and informed responses to examiners, and helps clients understand each step and grow in their understanding of the IP protection process."

IAM Patent 2022 Client Interview

"Excellent technical licensing and deal-making skills, [a] can-do attitude and an inherent sense of value to each assignment"

Senior Leader, Corporate

"Andrew gave us the confidence that the final terms agreed were fair and in line with the current best practice"

UK University Head of Tech Transfer

"The work carried out by Symbiosis has always been of high quality. The team have a wealth of experience and understanding in life sciences, which means they are able to provide advice on patent filing from the earliest stage right through prosecution."

IAM Patent 2022 Client Interview

"Julie always asks the right questions and grasps the heart of the invention easily. Julie expresses herself very clearly and it is straightforward to communicate with her, in both written and oral form. She presents commercial strategies, thanks to her long experience in the field and concrete exposure to challenges that she has been able to overcome."

IAM Patent 2022 Client Interview

"Andrew lived up to our expectations, helping us take a very hard negotiation over the line. We enjoyed working with him and would do so again. I would definitely recommend him to organisations trying to navigate IP licensing negotiations"

UK CEO

"One of those rare breeds who manage to combine considerable technical expertise with a keen business sense"

Senior Leader, Corporate

"It is not an exaggeration to state that our confidence in Rob and Symbiosis is such that the strategic direction of our company has been IP-led at all times."

IAM Patent 2022 Client Interview

"It is a privilege to work with Symbiosis."

Prof. Richard Ross, CSO
Asterion Limited

"Symbiosis dives deep into the science and data and then gives an excellent assessment of the potential for the patent to be granted and the value of said patent."

IAM Patent 2022 Client Interview

"The service provided by Symbiosis is personal, efficient and highly professional."

IAM Patent 2022 Client Interview

"Cardiff University has a longstanding relationship with Symbiosis IP and we have always experienced a consistently high quality range of IP services. We particularly appreciate the ability to provide bespoke advice for academic, TTO or industry audiences as appropriate and this has contributed significantly to our translational successes across the life sciences portfolio."

Rhodri Turner
Senior Technology Transfer Officer, Cardiff University

"Lee Samuel readily understands technology and consistently demonstrates thorough knowledge of patent law, great attention to detail and efficient organisational skills, leading to successful grants."

IAM Patent 2022 Client Interview

"Their communications are clear and always in good time for action to be taken. They have established a good network of foreign associates and we have recently had successful filings in the USA, Japan and China without a need for extensive office action and its associated costs."

IAM Patent 2022 Client Interview

Our use of cookies

We use necessary cookies to make our site work. We'd also like to set analytics cookies that help us make improvements by measuring how you use the site. These will be set only if you accept.

For more detailed information about the cookies we use, see our Cookies page. Cookie Control Link Icon


Necessary cookies

Necessary cookies enable core functionality such as security, network management, and accessibility. You may disable these by changing your browser settings, but this may affect how the website functions.